Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trinity Biotech PLC TRIB

Trinity Biotech plc is an Ireland-based commercial stage biotechnology company. The Company is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. It intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The Company, through EpiCapture Limited, is also developing a non-invasive test for monitoring the risk of aggressive prostate cancer. The Company sells its products direct in the United States and through a network of international distributors.


NDAQ:TRIB - Post by User

Post by ApexGain200on Nov 30, 2024 11:03am
29 Views
Post# 36338914

$TRIP: Long-Term Hold or Dead Money?

$TRIP: Long-Term Hold or Dead Money?I’m not convinced $TRIP is going to blow up anytime soon, but looking at the fundamentals, it’s not a disaster either. The stock’s down nearly 50% from its 52-week highs and trading at a pretty high P/E ratio, so it’s priced for perfection in a lot of ways. If you’re into long-term holds and believe in the travel rebound (which I do), $TRIP could be an interesting pick—especially with its brand recognition. But short-term? It’s tough to see a major catalyst unless they can reinvent themselves or deliver more on the earnings front. I’m also following $BOLT closely though. Rumor has it, that one’s got some serious upside potential, so if $TRIP doesn’t move, I might look for action there. Anyone here taking the long shot with $TRIP or just avoiding?
<< Previous
Bullboard Posts
Next >>